NeoChord

About:

NeoChord is a medical device company that develops devices that allow mitral valve repair to be performed on a beating heart.

Website: http://neochord.com

Top Investors: Deerfield, U.S. Venture Partners, Baird Capital, Treo Ventures, Deerfield Capital Management

Description:

NeoChord is a medical device company that has developed a proprietary device that allows mitral valve repair to be performed on a beating heart through a 2 to 3-inch incision between the ribs in patients with severe, degenerative mitral valve regurgitation. In contrast, most mitral valve repair procedures are performed through a 3 to 10-inch chest incision (sternotomy) which involves cutting through the sternum, opening the rib cage, stopping the heart and placing the patient on bypass. Founded in 2007 and is based in St. Louis Park, MN.